 | Zacks: Brokerages Expect Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Will Announce Earnings of -$1.49 Per Share
www.americanbankingnews.com - February 14 at 11:13 AM |
| Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Sees Large Increase in Short Interest
www.americanbankingnews.com - February 11 at 6:26 PM |
 | Tonix Pharmaceuticals Prices $7.5 million Public Offering
finance.yahoo.com - February 7 at 9:07 AM |
 | BTAI Hits A High, TNXP's RECOVERY Fails, MRK Plans A Spin-off
www.nasdaq.com - February 6 at 8:14 AM |
 | Tonix Pharmaceuticals down 60% premarket on failed Tonmya study
seekingalpha.com - February 6 at 8:14 AM |
| Tonix Pharmaceuticals Announces Outcome of Interim Analysis for Phase 3 RECOVERY Study of Tonmya® (TNX-102 SL) in PTSD
finance.yahoo.com - February 5 at 7:10 PM |
| Tonix Pharmaceuticals to Participate in Upcoming February Investor Conferences
finance.yahoo.com - February 4 at 8:49 AM |
| Financial Contrast: Acerus Pharmaceuticals (OTCMKTS:TRLPF) versus Tonix Pharmaceuticals (OTCMKTS:TNXP)
www.americanbankingnews.com - February 2 at 10:42 PM |
| Tonix Pharmaceuticals Moves Ahead, And Other News: The Good, Bad, And Ugly Of Biopharma
seekingalpha.com - January 30 at 6:46 PM |
| Does The Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Share Price Tend To Follow The Market?
finance.yahoo.com - January 29 at 6:26 PM |
| Tonix Pharmaceuticals Presented Results from a Preclinical Study of TNX-801, a Potential Vaccine to Prevent Smallpox and Monkeypox, in a Poster Presentation at the 2020 American Society for Microbiology (ASM) Biothreats Conference
finance.yahoo.com - January 29 at 6:26 PM |
| Company News for Jan 27, 2020
finance.yahoo.com - January 27 at 12:44 PM |
| Short Interest in Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Decreases By 66.6%
www.americanbankingnews.com - January 26 at 8:44 PM |
 | 6 Healthcare Stocks Moving In Friday's Pre-Market Session
www.benzinga.com - January 24 at 9:00 AM |
| 4 Biotechnology Stocks Moving In Friday's Pre-Market Session
www.benzinga.com - January 24 at 9:00 AM |
| Tonix Pharma up 42% premarket on advancement of TNX-102 SL
seekingalpha.com - January 24 at 9:00 AM |
| Tonix Pharmaceuticals Announces Successful Completion of a Fed-Fasting and Dose Proportionality Study of TNX-102 SL
finance.yahoo.com - January 24 at 9:00 AM |
| Tonix Pharmaceuticals to Present Results from Preclinical Study of TNX-801 in a Poster Presentation at the 2020 American Society for Microbiology (ASM) Biothreats Conference
finance.yahoo.com - January 23 at 12:59 PM |
| Tonix Pharma files for equity offering; shares down 9% premarket
seekingalpha.com - January 21 at 7:59 AM |
| Tonix Pharmaceuticals Holding (TNXP) Presents At Biotech Showcase 2020 - Slideshow
seekingalpha.com - January 14 at 3:49 PM |
 | Thinking about buying stock in Canopy Growth Corp, FuelCell Energy, LYFT, Square, or Tonix Pharmaceuticals?
www.marketwatch.com - January 7 at 4:06 PM |
| Tonix Pharmaceuticals to Present at Biotech Showcase 2020
finance.yahoo.com - January 7 at 4:06 PM |
| Tonix Pharma up 10% on development plan for once-daily MDD pill
seekingalpha.com - December 16 at 5:37 PM |
| Tonix Pharmaceuticals Announces Plan to Develop TNX-601 CR Tablets for Once-Daily Treatment of Major Depressive Disorder, in Addition to PTSD, After Successful Completion of Phase 1 Pharmacokinetic Study
finance.yahoo.com - December 16 at 5:37 PM |
| TNXP: TNX-102 SL P3 PTSD Trial Interim Readout in 1Q20; P3 Trial in Fibromyalgia Underway…
finance.yahoo.com - December 16 at 12:36 PM |
 | Tonix Vaults on European Patent
www.baystreet.ca - December 12 at 2:21 PM |
| Tonix Pharma nabs European patent covering TNX-102 SL; shares up 22% AH
seekingalpha.com - December 11 at 5:28 PM |
| Tonix Pharmaceuticals Announces New European Patent for the Composition and Formulation of TNX-102 SL
finance.yahoo.com - December 11 at 5:28 PM |
| Tonix Pharma begins patient enrollment in late-stage RELIEF study for fibromyalgia
seekingalpha.com - December 10 at 12:56 PM |
| Tonix Pharmaceuticals Enrolls First Patient in Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia
finance.yahoo.com - December 10 at 7:55 AM |
| Tonix Pharmaceuticals to Present at 12th Annual LD Micro Main Event
finance.yahoo.com - December 4 at 8:38 AM |
| Tonix Pharmaceuticals Announces Receipt of FDA Official Minutes from Breakthrough Therapy Type B Clinical Guidance Meeting for Tonmya® as a Potential New Treatment for PTSD
finance.yahoo.com - November 26 at 8:30 PM |
| Tonix Pharmaceuticals to Participate in Benchmark’s Annual Discovery 1x1 Conference
finance.yahoo.com - November 25 at 7:59 PM |
| Tonix Pharmaceuticals Announces Initiation of the Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia
finance.yahoo.com - November 21 at 12:58 PM |
| Tonix Plans Regulatory Filing To Kick Off Study Of Alcohol Use Disorder Drug
finance.yahoo.com - November 21 at 12:58 PM |
| Tonix Pharma up 12% after hours on advancement of TNX-102 SL in AUD
seekingalpha.com - November 20 at 7:31 PM |
| Tonix Pharmaceuticals Completes Pre-IND Meeting with FDA for TNX-102 SL as a Clinical Candidate for Alcohol Use Disorder
finance.yahoo.com - November 20 at 7:31 PM |
| Tonix Pharmaceuticals Announces Closing of $9.0 Million Public Offering
finance.yahoo.com - November 20 at 7:44 AM |
| Tonix Pharmaceuticals Prices $9.0 Million Public Offering
finance.yahoo.com - November 15 at 9:07 AM |
| Tonix Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights
finance.yahoo.com - November 8 at 7:29 PM |
| Tonix Pharmaceuticals Announces 12-Week Primary Endpoint and Addition of Adaptive Design Features in the Currently-Enrolling Phase 3 RECOVERY Study of Tonmya® for PTSD, Following FDA Meeting
finance.yahoo.com - November 4 at 9:04 AM |
| Tonix Pharma up 24% after reverse split
seekingalpha.com - November 1 at 11:20 PM |
| Companies Like Tonix Pharmaceuticals Holding (NASDAQ:TNXP) Can Be Considered Quite Risky
finance.yahoo.com - October 30 at 6:17 PM |
| Tonix Pharmaceuticals Holding (TNXP) Investor Presentation - Slideshow
seekingalpha.com - October 29 at 8:58 AM |
| Tonix Pharmaceuticals Announces Issuance of U.S. Patent for Crystalline Tianeptine Oxalate Salt, the Active Ingredient of TNX-601
finance.yahoo.com - October 23 at 8:00 AM |
| Tonix Pharma files to offer 16.7M shares
seekingalpha.com - October 18 at 11:26 PM |
 | BRIEF-Tonix Pharmaceuticals Holding Files For Offering 16.7 Mln Shares Of Common Stock
www.msn.com - October 18 at 6:26 PM |
| Tonix Pharmaceuticals Joins the Alliance for Biosecurity
finance.yahoo.com - October 15 at 8:43 AM |
| Tonix Pharmaceuticals Announces that the European Patent Office Opposition Division Has Upheld Its Patent for the Use of the Active Ingredient in TNX-102 SL, Cyclobenzaprine, for the Treatment of PTSD
finance.yahoo.com - October 7 at 8:04 AM |
| Tonix Pharmaceuticals Announces Completion of Long-Term Exposure Studies in Participants with PTSD to Evaluate the Tolerability of TNX-102 SL 5.6 mg
finance.yahoo.com - October 3 at 9:18 AM |
